News

You are here

CE-IVD marked
Novosanis achieved two major milestones - our Colli-Pee ® Small Volumes product line is now CE-Marked.
IUSTI2018
Novosanis attended IUSTI2018 from June 26 to June 30 in Dublin, Ireland. Our Colli-Pee device suited for first-void urine collection allowing for improved detection of STIs was on display...
Colli-Pee
Colli-Pee US FDA registered
Prostate cancer is the most common male cancer, with around 400,000 new cases every year in Europe.

Pages